APOA4 抗体 (AA 21-396)
Quick Overview for APOA4 抗体 (AA 21-396) (ABIN7144403)
抗原
See all APOA4 抗体适用
宿主
克隆类型
标记
应用范围
- 
    - 
                                            抗原表位
- AA 21-396
- 
                                            交叉反应
- 人
- 
                                            纯化方法
- >95%, Protein G purified
- 
                                            免疫原
- Recombinant Human Apolipoprotein A-IV protein (21-396AA)
- 
                                            亚型
- IgG
 
- 
                                            
- 
    
- 
    - 
                                            应用备注
- Recommended dilution: WB:1:1000-1:5000,
- 
                                            限制
- 仅限研究用
 
- 
                                            
- 
    - 
                                            状态
- Liquid
- 
                                            缓冲液
- 
                        Preservative: 0.03 % Proclin 300
 Constituents: 50 % Glycerol, 0.01M PBS, PH 7.4
- 
                                            储存液
- ProClin
- 
                                            注意事项
- This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
- 
                                            储存条件
- -20 °C,-80 °C
- 
                                            储存方法
- Upon receipt, store at -20°C or -80°C. Avoid repeated freeze.
 
- 
                                            
- 
    - APOA4 (Apolipoprotein A-IV (APOA4))
- 
                                            别名
- APOA4
- 
                                            背景
- 
                        Background: May have a role in chylomicrons and VLDL secretion and catabolism. Required for efficient activation of lipoprotein lipase by ApoC-II, potent activator of LCAT. Apoa-IV is a major component of HDL and chylomicrons. Aliases: APOA4Apolipoprotein A-IV antibody, Apo-AIV antibody, ApoA-IV antibody, Apolipoprotein A4 antibody 
- 
                                            UniProt
- P06727
- 
                                            途径
- Lipid Metabolism
 抗原
- 
                    
 
                                     
                                     
                                    